Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Chan

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 26, 2000
CK-MB isoforms for early risk stratification of emergency department patientsG B Green, E Dehlinger, T S McGrievey, et al.
Cancer Letters|April 27, 2001
Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patientsY Wang, F P Kuhajda, J N Li, et al.
The Journal of Urology|July 1, 1993
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerA W Partin, J Yoo, H B Carter, et al.
Urology|April 1, 1995
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocityH B Carter, J D Pearson, Z Waclawiw, et al.
Science (New York, N.Y.)|February 24, 1995
Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell lineS P Lees-Miller, R Godbout, D W Chan, et al.
The New England Journal of Medicine|May 21, 1992
Hepatitis B and hepatitis C in emergency department patientsG D Kelen, G B Green, R H Purcell, et al.
The Journal of Urology|July 29, 1998
Influence of radical prostatectomy on serum hormone levelsL R Miller, A W Partin, D W Chan, et al.
Urology|February 1, 1997
Prostate-specific antigen in men born with bladder exstrophyR I Silver, A W Partin, J I Epstein, et al.
Annals of Emergency Medicine|September 1, 1991
The potential utility of a rapid CK-MB assay in evaluating emergency department patients with possible myocardial infarctionG B Green, K N Hansen, D W Chan, et al.
Urology|August 12, 1999
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative modelW J Catalona, A W Partin, J A Finlay, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 26, 2000
CK-MB isoforms for early risk stratification of emergency department patientsG B Green, E Dehlinger, T S McGrievey, et al.
Cancer Letters|April 27, 2001
Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patientsY Wang, F P Kuhajda, J N Li, et al.
The Journal of Urology|July 1, 1993
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerA W Partin, J Yoo, H B Carter, et al.
Urology|April 1, 1995
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocityH B Carter, J D Pearson, Z Waclawiw, et al.
Science (New York, N.Y.)|February 24, 1995
Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell lineS P Lees-Miller, R Godbout, D W Chan, et al.
The New England Journal of Medicine|May 21, 1992
Hepatitis B and hepatitis C in emergency department patientsG D Kelen, G B Green, R H Purcell, et al.
The Journal of Urology|July 29, 1998
Influence of radical prostatectomy on serum hormone levelsL R Miller, A W Partin, D W Chan, et al.
Urology|February 1, 1997
Prostate-specific antigen in men born with bladder exstrophyR I Silver, A W Partin, J I Epstein, et al.
Annals of Emergency Medicine|September 1, 1991
The potential utility of a rapid CK-MB assay in evaluating emergency department patients with possible myocardial infarctionG B Green, K N Hansen, D W Chan, et al.
Urology|August 12, 1999
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative modelW J Catalona, A W Partin, J A Finlay, et al.
Pageof 17